Here's Why I Wouldn't Touch Rigetti Computing With a 10-Foot Pole

Rigetti Computing’s stock has rallied (up >45% in 2025 and >10% year-to-date in 2026) but the firm faces material technical shortcomings: its two-qubit gate fidelity is 99.5% versus 99.99% at rival IonQ and below the ~99.9% threshold commonly cited for effective error correction. The company failed to advance to Stage B of DARPA’s Quantum Benchmarking Initiative and delayed its 108-qubit Cepheus-1-108Q to address error rates, although it did secure an $8.4 million order from India’s CDAC and received a few sell-side buy calls. These accuracy deficits and the DARPA snub materially weaken Rigetti’s competitive positioning despite speed claims and small commercial wins, implying downside risk for the equity until fidelity improves or a clearer path to error correction is demonstrated.

Analysis

Market structure: The article reallocates demand toward high-fidelity vendors (IONQ) and away from speed-first players (RGTIW). Customers with mission-critical or defense use-cases will pay a premium for >=99.9% two-qubit gate fidelity, shifting pricing power to providers who can demonstrably hit that threshold; expect 10–30% price premiums for validated enterprise/defense deals in 12–24 months. Small orders (India $8.4M) are noise versus institutional DARPA contracts; missing Stage B materially reduces RGTIW's addressable near-term TAM for government spend.

Risk assessment: Tail risks include (1) operational: RGTIW fails to raise cash and dilutes equity within 6–12 months, (2) regulatory/defense: DARPA/DoD favors IONQ or others for classified programs, and (3) technological: a competitor announces <99.5% error correction breakthrough making RGTIW obsolete. Immediate price moves (days) will be sentiment-driven, near-term (weeks–months) revenue/contract risk from Cepheus delays, long-term (2–5 years) depends on hardware fidelity improvements and software error-correction adoption. Hidden dependencies include cryogenic supply chains, qubit fabrication partners, and independent benchmarking reporting timelines; key catalysts are DARPA Stage B selections, Cepheus-1-108Q published fidelity tests, and quarterly revenue guidance.

Trade implications: Direct: establish a tactical short RGTIW position (1.0–2.0% NAV) or a 3–6 month bear-put spread to limit downside risk; target 30–50% downside within 6–12 months, stop-loss if RGTIW reports independently verified two-qubit fidelity >=99.9% or wins a major government contract. Pair: long IONQ (1.5–3.0% NAV) vs short RGTIW equal notional — expected relative outperformance 25–60% if DARPA/defense spend flows to high-fidelity vendors in 3–12 months. Options: use debit spreads to buy downside protection on RGTIW (buy 6-month puts, sell lower strike) and a call spread on IONQ ahead of potential DARPA/earnings upside.

Contrarian angles: Consensus underweights niche markets where speed>accuracy (e.g., approximate optimization, some finance simulations) where RGTIW could commercialize near-term revenues; a successful Cepheus fidelity fix by mid-2026 would be a 1–2x re-rating event. The market may be overpricing insolvency risk — check cash runway (burn + expected orders) over next 90 days — and underpricing short-squeeze risk given retail interest in quantum names. Historical parallel: early GPU hardware incumbents stumbled vs software-optimized rivals but recovered with IP/licensing deals; similar licensing or cloud partnerships could salvage RGTIW’s value if they pivot quickly.

Key Decisions for Investors

• Establish a tactical short position in RGTIW equal to 1.0–2.0% of portfolio NAV or buy a 3–6 month bear-put spread (limit downside, finance with sale of lower-strike put); target a 30–50% nominal decline in 6–12 months, stop-loss if RGTIW publishes independently verified two-qubit fidelity >=99.9% or signs a defense contract within 90 days.
• Initiate a pair trade: long IONQ (1.5–3.0% NAV) and short RGTIW equal notional. Hold 3–12 months; take profits if IONQ outperforms RGTIW by >25% or after DARPA Stage B announcements confirm funding allocation.
• Use options to express asymmetric views: buy a 6-month RGTIW put and sell a lower-strike put (bear-put spread) sized to hedge existing quantum exposure; concurrently purchase a 3–6 month IONQ call spread (debit) ahead of potential DARPA/earnings catalysts.
• Rotate 1–3% of tech allocation away from early-stage quantum hardware names and into NVDA (ticker NVDA) and quantum software/consulting vendors that monetize near-term classical-quantum workflows; target reallocation within 30 days and reassess after each quarterly report.
• Monitor three binary triggers over the next 60–120 days before increasing positions: (A) DARPA Stage B selections, (B) Cepheus-1-108Q independent fidelity report, and (C) RGTIW cash-runway disclosure — act to close shorts or trim longs if any trigger reverses the current technological narrative.